VAPAWAY.EU - Research and education on VAP prevention
  • Home
  • Articles
  • GuideLines
  • Links
  • About VAPAWAY
  • Training
  • Contacts

Login








Lost Password?

Register to receive updated data on VAPAWAY initiative

Agenda

 

9 - 12 March 2010

ISICEM International Symposium on Intensive Care and Emergency Medicine - Brussels (Belgium)

ISICEM

 

9 -11 June 2010

EACTA European Association of Cardiothoracic Anaesthesiologists - Edinburgh (UK)

EACTA

 

12-15 June 2010

ESA European Society of Anaesthesiology - Helsinki (Finland)

ESA

 

18-22 September 2010

ERS European Respiratory Society - Barcellona (Spain)

ERS

 

9 -13 October 2010

ESICM European Society of Intensive Care Medicine - Barcellona (Spain)

ESICM

  

 

> International events   

> Local events 

UTILITY OF PRELIMINARY BRONCHOALVEOLAR LAVAGE RESULTS IN SUSPECTED VENTILATOR -ASSOCIATED PNEUMONIA PDF Print E-mail
Friday, 06 March 2009
 
Swanson JM, Wood GC, Croce MA, Mueller EW, Boucher BA, Fabian TC.
Department of Clinical Pharmacy, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
J Trauma. 2008 Dec;65(6):1271-7.

BACKGROUND: More than one half of lower respiratory cultures are negative for ventilator-associated pneumonia (VAP) and final reporting requires 72 hours to 96 hours. A previous retrospective study concluded that preliminary bronchoalveolar lavage (BAL) culture results (pBAL), reported at approximately 24 hours, accurately predicted final BAL culture results (fBAL). Our objective was to verify the predictive value of pBALs for fBALs, and evaluate the use of insignificant (1-99,999 cfu/mL) pBALs for rapid discontinuation of empirical antibiotics.

METHODS: All BALs performed in the intensive care unit (ICU) of the Presley Regional Trauma Center were used to compare pBALs with fBALs. Trauma intensive care unit patients whose antibiotics were discontinued using pBALs (study group), were compared with a historical control group who had their antibiotics discontinued using fBALs.

RESULTS: Preliminary and final results of 474 prospectively collected BALs were compared. Significant pBALs had a positive predictive value of 100%, whereas the negative predictive values of "no growth to date" and insignificant pBALs were 99% and 95%, respectively. Study patients (n = 176) were similar to control patients (n = 112) except for a higher median injury severity score (34 vs. 29; p < 0.001). The median (interquartile range) duration of empirical antibiotic therapy in patients without VAP was shorter for study patients [1.5 (1.25, 2) vs. 3 (3, 4) days, p < 0.001]. Empirical antibiotics were temporarily interrupted in four patients with VAP because of falsely negative pBALs without adverse clinical sequelae.

CONCLUSIONS: Preliminary BALs were highly predictive for final results. Using insignificant pBALs appears to be a safe strategy for promptly discontinuing empirical antibiotics in trauma patients with suspected VAP.

Last Updated ( Friday, 06 March 2009 )
 
< Prev   Next >
Select and watch
from the following webinars

 


Join us on www.smartonweb.org

Partner

VAPAWAY is proudly supported by Covidien.

http://www.covidien.com